aspirin use based on data collected at baseline and at additional time points prior to hospitalization for pneumonia if these data were available. Aspirin use was similar between the 2 groups, suggesting that confounding by unaccounted aspirin use is unlikely.
Sedation Protocol for Critically Ill Pediatric Patients
To the Editor In the Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) trial, Dr Curley and colleagues 1 found that a nurse-implemented, goal-directed sedation protocol for children undergoing mechanical ventilation for acute respiratory failure did not reduce the duration of mechanical ventilation compared with standard of care. In an accompanying Editorial, Dr Mehta 2 raised the question of whether a low adherence rate to a complex protocol (71%-100%) or a difference in administered drugs with bioaccumulation between the groups contributed to the null findings. This large randomized clinical trial of sedation using a bedside protocol in critically ill children may have been confounded by an intervention group who were younger and less sick and who received more frequent assessments. In Reply Dr Remy is concerned that null findings of the RESTORE clinical trial may have been the result of the cluster randomized design leading to variation in sedation assessments between bedside nurses and among different centers. Remy asks whether measures of variation between bedside nurses were determined prior to the study, whether additional sedation measures were considered, and whether nurse turnover or experience could have confounded study results. During the RESTORE start-up phase, all PICUs implemented the SBS as a unit-based standard of care. The SBS was selected because it was the only valid and reliable sedation assessment instrument specific for intubated pediatric patients. The weighted κ scores of 0.44 to 0.76 noted by trial, all physicians and nurses received training and were required to successfully complete a posttest prior to enrolling patients. We established interrater reliability checks on the SBS and monitored interrater reliability throughout the trial in both intervention and control PICUs. The overall κ score for the SBS was 0.87 (95% CI, 0.83-0.91). Any PICU falling below 80% agreement implemented a quality improvement plan and the interrater reliability was rechecked.
As noted in our article and in the supplementary materials, sedation assessments were completed more frequently in the intervention compared with control PICUs, presumably because the data were used by the intervention PICUs to target sedation. Adherence to sedation assessment elements in our protocol was high; the daily SBS target was prescribed on 98% of intubation study days and achieved 95% of the time in intervention patients.
We have no data on how nurse turnover or experience may have confounded the RESTORE study. As noted in our supplemental materials, the experience level of the PICU nursing workforce was good, with a median of 6.2 years (interquartile range, 5.1-8.3 years) across sites, and most nurses had bachelor's degrees (median, 80%; interquartile range, 74%-90% across sites). In addition, we had few protocol deviations stemming from enrolled patients receiving care from a nurse who was not trained in using the RESTORE protocol.
Clinical trials and observational studies 2 may differ in their conclusions for the reasons that Remy cites, and there may be additional bias introduced in observational studies that may be difficult to identify, as well as the inherent differences between a toddler with acute respiratory failure and a 50-yearold adult with a medical or surgical problem.
